Drug Metabolism and Personalized Therapy

Drug Metabolism and Personalized Therapy 由 Walter de Gruyter 出版。按 OpenAlex 近年发文统计，该刊主要发表 Pharmacogenetics and Drug Metabolism、Genetic Associations and Epidemiology、Nutrition, Genetics, and Disease 等主题的论文，这 3 个主题约占 54.4%，主导子领域为 Pharmacology。（根据 OpenAlex 主题统计与中科院分区数据生成）

About this journal The current volume of Drug Metabolism and Personalized Therapy (DMPT) is open access via Subscribe to Open (S2O). All accepted articles will be published under a Creative Commons license at no cost to authors. Learn more about De Gruyter Brill’s Subscribe to Open program.ObjectiveDrug Metabolism and Personalized Therapy (DMPT) offers up-to-date research articles, reviews and opinion papers from the broad field of personalized therapy and pharmacogenomics. Specifically, it covers the following fields: pharmacogenetics, pharmacogenomics and drug metabolism research, dealing with established, new and potential drugs, herbal medicinal products, environmentally toxic chemicals, the mechanisms by which drugs and herbsc an interact with each other and with biological systems, and the pharmacological and toxicological consequencesof these interactions, as well as drug metabolism and excretion. More generally, it is concerned with the area of therapeutic individualization, particularly on the basis of pharmacogenetics, with regards to the use of pharmaceuticals and herbal medicine, including traditional medicine.DMPT is an online only journal that is published quarterly. All contributions submitted for publication in DMPT are subject to single-anonymized peer review by at least two experts in the field, selected and invited by the Editor-in-Chief and a dedicated Editorial Team. DMPT only publishes articles in English.Please submit your manuscript hereTopicsdrug metabolizing enzymes //pharmacogenetics and pharmacogenomics // biochemical pharmacology // molecular pathology // clinical phar macology // pharmacokinetics and drug-drug interactions // immunopharmacology // neuropsychopharmacology // herbal medicine and traditional medicineArticle formatsResearch Articles, Reviews and Mini Reviews, Opinion Papers, Short Communications, Letters to the Editor, Case Reports, EditorialsUseful links Instructions for AuthorsSubmission ChecklistTemplate for Ethical and Legal DeclarationsManuscript Preparation and Manuscript TemplatesResources for AuthorsLicense to PublishAuthor Language ServiceData Sharing PolicyRights and Permissions Your Benefits Specialized, comprehensive and cutting-edge approach to drug metabolism researchState-of-the-art research resultsHigh quality peer-reviewInternational readership and global reachEach article easily discoverable because of Search Engine Optimization (SEO) and comprehensive abstracting and indexing servicesSecure arch

摘自期刊官网 Aims & Scope

研究方向（LetPub）：Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)

主编 Adrián Llerena出版商官网

中科院期刊分区表

CiteScore 分区（Scopus，2026 年 6 月版）

Scopus 按 CiteScore 在每个学科内为期刊排名，百分位 75 及以上为 Q1，每 25 为一档；与中科院分区是不同体系。LetPub

数据库收录

ScopusLetPub

国际期刊预警名单：各版本均未列入LetPub

期刊官网自述收录

CAS出版商官网

其他：EBSCO、ProQuest、Baidu、OCLC

期刊官网列出的收录清单，未与各数据库逐一核对；Web of Science 各子库以上方记录为准。

不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。

影响力指标

CiteScore 2026-06

3.2LetPub · 2026-11-01

CiteScore（出版商公布）

3.2出版商官网 · 2026-11-01

SJR 2026-06

0.32LetPub · 2026-11-01

SNIP 2026-06

0.45LetPub · 2026-11-01

h-index

22OpenAlex · 2026-11-01

i10-index

89OpenAlex · 2026-11-01

两年平均被引

2.2OpenAlex · 2026-11-01

Gold OA 文章占比

0%LetPub · 2026-11-01

不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。

其他来源

评审方式

单盲同行评审出版商官网

社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。

费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。

出版商

Walter de Gruyter

ISSN

2363-8907

电子版 ISSN

2363-8915

官方链接

• 期刊主页 ↗OpenAlex
• 投稿系统 ↗出版商官网
• 专刊 / 特刊征稿 ↗出版商官网